GRAMPA: a test to measure basic movement skills in older adults
Official title: Prospective, Single-center Interventional Study to Assess the Reliability of the GRAMPA Score, Measuring the Graduation of Motor Abilities of the Elderly Patients Hospitalised
Run by Groupe Hospitalier Mutualiste de Grenoble · NCT07236866 · Data updated 2026-11-12
This project will test the GRAMPA scale to measure basic movement abilities in hospitalized patients aged 75 and older.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 75 Years and up |
| Sex | All |
| Enrollment | 55 (estimated) |
| Sponsor | Groupe Hospitalier Mutualiste de Grenoble Academic / other |
| Locations | 2 sites (Grenoble, Isere and 1 other locations) |
| Status | Recruiting |
| Started | November 7, 2025 |
| Main results expected | November 1, 2027 |
| Study ends | November 1, 2027 |
| Registry record updated | March 18, 2026 |
| Trial ID | NCT07236866 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are French-speaking patients aged 75 or older who are hospitalized in the geriatrics department at the Groupe Hospitalier Mutualiste de Grenoble and can understand instructions and give informed consent.
✕Probably not a fit
Patients who cannot follow instructions due to sensory or cognitive impairment, who have medical or surgical contraindications to transfers, or who cannot legally consent are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial implements the GRAMPA scale in the geriatrics wards of the Groupe Hospitalier Mutualiste de Grenoble to rate a set of basic movements such as rolling in bed, getting in and out of bed, and sit-to-stand transfers. Trained clinicians will administer the scale to consenting patients aged 75 and over who can follow instructions and perform transfers, collecting standardized scores for each movement domain. The protocol excludes patients with medical or surgical contraindications to transfers, those who cannot understand instructions, and patients under legal protection who cannot consent. Data are intended to document the scale's ability to provide a graded, comprehensive profile of motor abilities to inform rehabilitation planning.
Why it matters
Potential benefit: If successful, the GRAMPA scale could give clinicians a clearer, more detailed and graded way to measure basic movements and set tailored rehabilitation goals for older patients.
How similar studies have gone: Existing tools like AGGIR, ADL, Tinetti and the Minimum Motor Test measure parts of mobility but do not provide a comprehensive, graded assessment of basic movements, so this approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 75 years 2. Patients hospitalized in the geriatrics department of the Grenoble Mutualist Hospital Group 3. Comprehension of the French language (understanding of instructions) 4. Signature of free and informed consent Exclusion Criteria: 1. Patients whose sensory and/or mental capacities do not allow them to understand the instructions for carrying out transfers. 2. Patients with medical or surgical contraindications making it impossible to carry out transfers. 3. Patients under legal protection or unable to express their consent.
Where it's running
-
Groupe Hospitalier Mutualiste de Grenoble
Grenoble, Isere, France Recruiting -
Groupe Hospitalier Mutualiste
Grenoble, Isere, France Recruiting
Study contacts
- Study coordinator: Steve SO Odezenne, physiotherapist
- Email: steve.odezenne@ghm-grenoble.fr
- Phone: 0033 4.76.70.70.00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients: Geriatric Screening in Action
This study tests whether using geriatric screening alongside adjuvant CDK4/6 inhibitors helps tailor therapy for adults aged 70 and older with early-stage breast cancer.
-
Practical geriatric assessment for older adults with early-stage non-small cell lung cancer receiving SBRT
This project will test whether a brief Practical Geriatric Assessment (PGA) can be used with adults 65+ who have stage I–II non-small cell lung cancer and are receiving stereotactic body radiation therapy to identify care needs and guide supportive referrals.
-
Geriatric Assessment to support older patients undergoing allo-HSCT
This study tests a multidimensional geriatric assessment to see how age, health, and disease factors relate to outcomes for older adults undergoing allogeneic stem cell transplantation.
-
Validation of a pain measurement tool for older adults in Turkey
This study is testing a new pain measurement tool for Turkish-speaking older adults to see if it accurately helps doctors understand their pain.
-
Testing the Berg Balance Scale in Albanian speakers
This project will test whether the Berg Balance Scale works well for Albanian-speaking adults with balance problems.
-
Exploring how older adults make cancer treatment decisions based on health assessments
This study tests if giving older adults with cancer early access to their health information helps them make better treatment decisions and feel more satisfied with their choices.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.